Cargando…
The impact of FDA and EMEA guidelines on drug development in relation to Phase 0 trials
An increase in the number of identified therapeutic cancer targets achieved through recent biomedical research has resulted in the generation of a large number of molecules that need to be tested further. Current development of (anticancer) drugs is a rather inefficient process that for an average n...
| Autores principales: | , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group
2007
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2360360/ https://www.ncbi.nlm.nih.gov/pubmed/17726450 http://dx.doi.org/10.1038/sj.bjc.6603925 |